Mini‐review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross‐priming and direct priming?
- 1 September 2003
- journal article
- review article
- Published by Wiley in European Journal of Immunology
- Vol. 33 (10) , 2645-2654
- https://doi.org/10.1002/eji.200324341
Abstract
Cross‐priming is the process whereby professional APC, mainly dendritic cells (DC), prime T cells by presenting antigens processed from proteins of other cells such as tumor cells or virus‐infected cells. It has been argued that the importance of cross‐priming of CD8+ CTL responses has been overemphasized, despite strong evidence that these mechanisms operate when infectious organisms, tumors or self antigens cannot efficiently access the biosynthetic MHC class I processing pathway of DC. Since DC are ideally equipped to capture exogenous antigen and also, particularly in the mature state, express costimulatory molecules, itis difficult to distinguish whether effects are due to cross‐presentation, costimulation, or both. Whether cross‐priming or cross‐tolerance occurs depends on the maturation state of the DC, as wellas the levels of MHC class I‐bound peptides they present. Cross‐presentation of tumor‐derived antigens has been demonstrated but, importantly, requires adequate APC activation to prime CTL responses. Similarly, cross‐presentation of antigens from infectious organisms appears to be common, and frequently leads to cross‐priming. Interactions between cross‐presenting DC, CD4+ cellsand CD8+ T cells in the establishment of immunological memory are still not well defined. Experiments utilizing DC depletion are needed to further examine the role of processes such as cross‐priming and costimulation in the immune response.Keywords
This publication has 80 references indexed in Scilit:
- Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapyEuropean Journal of Immunology, 2002
- The CD8α+ Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated AntigensThe Journal of Experimental Medicine, 2002
- Inducing Tumor Immunity through the Selective Engagement of Activating Fcγ Receptors on Dendritic CellsThe Journal of Experimental Medicine, 2002
- CD8+ T Cell Tolerance to a Tumor-associated Antigen Is Maintained at the Level of Expansion Rather than Effector FunctionThe Journal of Experimental Medicine, 2002
- Effector and memory T-cell differentiation: implications for vaccine developmentNature Reviews Immunology, 2002
- Roles of heat-shock proteins in innate and adaptive immunityNature Reviews Immunology, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Antigen presentation to CD8+ T cells: cross-priming in infectious diseasesCurrent Opinion in Immunology, 2001
- Consequences of Cell DeathThe Journal of Experimental Medicine, 2000
- Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative TumorsThe Journal of Experimental Medicine, 1998